Bosh sahifaVEEV • NYSE
add
Veeva Systems Inc
Yopilish kursi
232,03 $
Kunlik diapazon
234,47 $ - 237,79 $
Yillik diapazon
170,25 $ - 258,93 $
Bozor kapitalizatsiyasi
38,36 mlrd USD
Oʻrtacha hajm
1,28 mln
Narx/foyda
54,55
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | yan, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 720,89 mln | 14,31% |
Joriy xarajat | 351,47 mln | 9,35% |
Sof foyda | 195,62 mln | 32,72% |
Sof foyda marjasi | 27,14 | 16,13% |
Har bir ulushga tushum | 1,74 | 26,09% |
EBITDA | 198,36 mln | 37,85% |
Amaldagi soliq stavkasi | 20,20% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | yan, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,15 mlrd | 27,87% |
Jami aktivlari | 7,34 mlrd | 24,17% |
Jami passivlari | 1,51 mlrd | 19,06% |
Umumiy kapital | 5,83 mlrd | — |
Tarqatilgan aksiyalar | 162,70 mln | — |
Narxi/balansdagi bahosi | 6,47 | — |
Aktivlardan daromad | 6,83% | — |
Kapitaldan daromad | 8,21% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | yan, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 195,62 mln | 32,72% |
Operatsiyalardan naqd pul | 69,54 mln | 20,38% |
Sarmoyadan naqd pul | -15,69 mln | 81,90% |
Moliyadan naqd pul | 20,81 mln | 298,50% |
Naqd pulning sof oʻzgarishi | 74,27 mln | 284,65% |
Boʻsh pul | 8,39 mln | -54,94% |
Haqida
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service in the life-science industry.
Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. As of May 5, 2022, it has a market capitalization of US$27.5 billion.
On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly-traded company to convert to a public benefit corporation.
On December 1, 2022, Veeva announced it would not renew its Salesforce partnership when it expired in September 2025, choosing instead to migrate Veeva CRM onto its own Vault Platform. The decision ended a 15+ year collaboration that had given Veeva approximately 80% market share in the life sciences CRM space. Wikipedia
Tashkil etilgan
2007
Sayt
Xodimlar soni
7 291
